Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives

被引:621
作者
Nagle, Dale G. [1 ]
Ferreira, Daneel
Zhou, Yu-Dong
机构
[1] Univ Mississippi, Sch Pharm, Pharmaceut Sci Res Inst, Dept Pharmacognosy, University, MS 38677 USA
[2] Univ Mississippi, Sch Pharm, Pharmaceut Sci Res Inst, Natl Ctr Nat Prod Res, University, MS 38677 USA
关键词
Camellia sinensis; green tea; catechins; flavonols; epigallocatechin-3-gallate; EGCG; clinical trials; cancer chemoprevention;
D O I
10.1016/j.phytochem.2006.06.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The compound (-)-epigallocatechin-3-gallate (EGCG) is the major catechin found in green tea [Camellia sinensis L. Ktze. (Theaceae)]. This polyphenolic compound and several related catechins are believed to be responsible for the health benefits associated with the consumption of green tea. The potential health benefits ascribed to green tea and EGCG include antioxidant effects, cancer chemoprevention, improving cardiovascular health, enhancing weight loss, protecting the skin from the damage caused by ionizing radiation, and others. The compound EGCG has been shown to regulate dozens of disease-specific molecular targets. Many of these molecular targets are only affected by concentrations of EGCG that are far above the levels achieved by either drinking green tea or consuming moderate doses of green tea extract-based dietary supplements. In spite of this, well-designed double-blinded controlled clinical studies have recently demonstrated the efficacy of green tea extracts and purified EGCG products in patients. Therefore, this review highlights results from what the authors believe to be some of the most clinically significant recent studies and describes current developments in the stereoselective total synthesis of EGCG. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1849 / 1855
页数:7
相关论文
共 33 条
[1]
Green tea polyphenols: Novel and potent inhibitors of squalene epoxidase [J].
Abe, I ;
Seki, T ;
Umehara, K ;
Miyase, T ;
Noguchi, H ;
Sakakibara, J ;
Ono, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 268 (03) :767-771
[2]
Molecular targets for green tea in prostate cancer prevention [J].
Adhami, VM ;
Ahmad, N ;
Mukhtar, H .
JOURNAL OF NUTRITION, 2003, 133 (07) :2417S-2424S
[3]
Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions [J].
Ahn, WS ;
Yoo, J ;
Huh, SW ;
Kim, CK ;
Lee, JM ;
Namkoong, SE ;
Bae, SM ;
Lee, IP .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2003, 12 (05) :383-390
[4]
A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G1 arrest, and regulation of gene expression [J].
Ahn, WS ;
Huh, SW ;
Bae, SM ;
Lee, IP ;
Lee, JM ;
Namkoong, SE ;
Kim, CK ;
Sin, JI .
DNA AND CELL BIOLOGY, 2003, 22 (03) :217-224
[5]
Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study [J].
Bettuzzi, S ;
Brausi, M ;
Rizzi, F ;
Castagnetti, G ;
Peracchia, G ;
Corti, A .
CANCER RESEARCH, 2006, 66 (02) :1234-1240
[6]
Boik J.C., 2001, NATURAL COMPOUNDS CA, P251
[7]
Green tea and cancer in humans: A review of the literature [J].
Bushman, JL .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1998, 31 (03) :151-159
[8]
A CHEMICAL-SCREENING STRATEGY FOR THE DEREPLICATION AND PRIORITIZATION OF HIV-INHIBITORY AQUEOUS NATURAL-PRODUCTS EXTRACTS [J].
CARDELLINA, JH ;
MUNRO, MHG ;
FULLER, RW ;
MANFREDI, KP ;
MCKEE, TC ;
TISCHLER, M ;
BOKESCH, HR ;
GUSTAFSON, KR ;
BEUTLER, JA ;
BOYD, MR .
JOURNAL OF NATURAL PRODUCTS, 1993, 56 (07) :1123-1129
[9]
Chiu AE, 2005, DERMATOL SURG, V31, P855
[10]
Chow HHS, 2003, CLIN CANCER RES, V9, P3312